Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
-
Notable Analyst Rating Changes 9/24: MTH, NSM, WFC, AIMC, CPN, SHFL Higher; LLL, AZN, VIP, ANN, KGC, UFS Downgraded
-
Notable Analyst Rating Changes 8/20: SOL, JACK, PRU, LULU, CHA Upgraded; RF, BCSI, AZN, BUCY, JOYG, UA Downgraded
-
David Moenning's Daily State of the Markets: 6/15
-
Deutsche Bank Upgrades MAP Pharmaceuticals (MAPP) to Buy
-
Notable Analyst Rating Changes 1/30: TER, TRA, AZN, BSX Upgraded; X, ALL, SGP, UA Downgraded
-
Deutsche Bank Upgrades AstraZeneca (AZN) to Buy
-
Deutsche Bank Said Don't Pin Your Hopes On a AstraZeneca (AZN) Takeover Following PFE/WYE Deal
-
Trading Radar for 10/30: ExxonMobil (XOM), Motorola (MOT), Colgate-Palmolive (CL), Sun Microsystems (JAVA) Report; GDP for Q3, Initial Jobless Claims Due
-
David Moenning's Daily State of the Markets: 10/23
-
Pre-Open Movers 9/11: Lehman (LEH) In Free-Fall On Worries, Other I-Banks Follow (MER, GS, MS, C); CSX (CSX) Up on Raised Guidance
-
Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
-
Notable Analyst Rating Changes 4/2: VOD, CHL, AZN Upgraded; UST, CROX, DKS Downgraded
